Catalyst Wire Dossier Catalyst Wire Dossier

oral cyclophosphamide

cyclophosphamide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for oral cyclophosphamide, covering 2023-05-26 to 2023-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS [Phase 2]

See pricing